|4Dec 11, 4:08 PM ET

DEMAREE JOHN 4

4 · G1 Therapeutics, Inc. · Filed Dec 11, 2018

Insider Transaction Report

Form 4
Period: 2018-12-10
DEMAREE JOHN
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2018-12-10$33.15/sh+1,000$33,1515,250 total

Documents

2 files